There were no significant differences in clinicopathological parameters or BI-RADS 3–5 microcalcifications between the LN (−) and LN (+) invasive ductal carcinoma (Luminal A, HER2, Basal molecular subtype). Here, ERBB2 is linked to invasive ductal breast carcinoma.